Print Page  |  Contact Us  |  Sign In  |  Register
News & Press: General News

Akcea's Novel Drug Cuts Lipoprotein(a)

Friday, September 13, 2013  
Posted by: Sandra Tremulis
Share |

Lipoprotein(a) is an emerging risk factor for cardiovascular disease, but there are limited options for lowering elevated levels.AMG145, a fully human monoclonal antibody to a protein synthesized and secreted by the hepatocyte, that binds to the low-density lipoprotein (LDL) receptor, significantly reduced Lp(a) among subjects with hypercholesterolemia receiving statin therapy.

 

http://www.medpagetoday.com/Cardiology/Dyslipidemia/41269


Community Search
Sign In
Login with LinkedIn
OR
Sign In securely
Latest News
Featured Members

 
809 Laurel Street
San Carlos, CA 94070
650/995.3242